ASCELIA PHARMA IS AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY

See our company presentation

Product pipeline

Lead candidate Mangoral (Phase III) is an MRI imaging drug being developed for detection and localization of liver metastases.

Oncoral (phase II ready) is a novel tablet-based irinotecan formulation, intended for treatment of advanced gastric (stomach) cancer.

Events